Pulmonary hypertension and reduced cardiac output during inhibition of nitric oxide synthesis in human septic shock

Shock

Volumn 9, Issue 6, 1998, Pages 451-454

  Avontuur, Jurgen A M ^a   Biewenga, Martine ^a   Buijk, Steven L C E ^a   Kanhai, Karan J K ^a   Bruining, Hajo A ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME INHIBITOR; N(G) NITROARGININE METHYL ESTER; NITRATE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITE;

AGED; ARTICLE; BIOSYNTHESIS; BLOOD; CASE REPORT; DRUG ANTAGONISM; HEART OUTPUT; HEMODYNAMICS; HUMAN; MALE; PATHOPHYSIOLOGY; PILOT STUDY; PULMONARY HYPERTENSION; SEPTIC SHOCK;

AGED; CARDIAC OUTPUT; ENZYME INHIBITORS; HEMODYNAMIC PROCESSES; HUMANS; HYPERTENSION, PULMONARY; MALE; NG-NITROARGININE METHYL ESTER; NITRATES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITES; PILOT PROJECTS; SHOCK, SEPTIC;

EID: 0032085844     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-199806000-00010     Document Type: Article

References (17)

1. Parrillo JE: Pathogenetic mechanisms of septic shock. N Engl J Med 328:953-963, 1993.
2. Moncada S, Palmer RM, Higgs EA: Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol Rev 43:109-142, 1991.
3. Palmer RM, Ashton DS, Moncada S: Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 333:664-666, 1988.
4. Avontuur JA, Bruining HA, Ince C: Nitric oxide causes dysfunction of coronary autoregulation in endotoxemic rats. Cardiovasc Res 35:368-376, 1997.
5. Rees DD, Palmer RM, Schulz R, et al: Characterisation of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br J Pharmacol 101:746-752, 1990.
6. Meyer J, Traber LD, Nelson S, et al: Reversal of hyperdynamic responses to continuous endotoxin administration by inhibition of NO synthesis: J Appl Physiol 73:324-328, 1992.
7. Petros A, Lamb G, Leone A, et al: Effects of a nitric oxide synthase inhibitor in humans with septic shock. Cardiovasc Res 28:34-39, 1994.
8. Kiehl MG, Ostermann H, Meyer J, Kienast J: Nitric oxide synthase inhibition by L-NAME in leukocytopenic patients with severe septic shock. Intens Care Med 23:561-566, 1997.
9. Bone RC, Fischer CJ, Clemmer TP, et al: The sepsis syndrome: A valid clinical entity. Crit Care Med 17:389-393, 1989.
10. G-nitro-L-arginine methylester in canine blood in vitro. Arch Pharmacol 347:342-345, 1993.
11. Green LC, Wagner DA, Glogowski J, et al: Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem 126:131-138, 1982.
12. Lundberg JM, Weitzberg E, Alving K, Rudehill A: Nitric oxide inhalation causes vasodilatation in bronchial and pulmonary circulation and attenuates pulmonary endotoxin effect. J Vasc Res 29:161, 1992.
13. Rossaint R, Falke KJ, Slama K, et al: Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med 328:399-405, 1993.
14. G-nitro-L-arginine-methyl-ester on cardiopulmonary function and biosynthesis of cyclooxygenase products during porcine endotoxemia. Crit Care Med 25:1051-1058, 1997.
15. Avontuur JA, Bruining HA, Ince C: Inhibition of nitric oxide synthesis causes myocardial ischemia in endotoxemic rats. Circ Res 76:418-425, 1995.
16. Kilbourn RG, Szabo C, Traber DL: Beneficial versus detrimental effects of nitric oxide synthase inhibitors in circulatory shock: lessons learned from experimental and clinical studies. Shock 7:235-246, 1997.
17. Lambert LE, Whitten JP, Baron BM, et al: Nitric oxide synthesis in the CNS, endothelium and macrophages differs in its sensitivity to inhibition by arginine analogues. Life Sci 48:69-75, 1991.